Market cap of gene and cell therapy companies 2023

Market capitalization of selected gene and cell therapy companies worldwide as of 2023

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2023

Region

Worldwide

Survey time period

as of March 31, 2023

Supplementary notes

This statistic does not include big pharma companies involved in cell and gene therapies, like Bayer, BMS, Novartis, Roche, etc. Additionally, it does not include companies focused on CRISPR/Cas9.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Cell and gene therapy "

Other statistics that may interest you Cell and gene therapy

Market overview

6

R&D/trials

5

Stem cells

5

Cord blood

5

CAR/CAR-T

4

Miscellaneous

5

Further related statistics

18
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.